<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The oral administration of <z:chebi fb="0" ids="6775">mesalazine</z:chebi> (<z:chebi fb="0" ids="6775">5-aminosalicylic acid</z:chebi>) resulted in the exacerbation of <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> in two patients intolerant to sulphasalazine whose <z:hpo ids='HP_0002583'>colitis</z:hpo> had previously been quiescent </plain></SENT>
<SENT sid="1" pm="."><plain>Although sulphasalazine intolerance is usually attributable to the <z:chebi fb="0" ids="132842">sulphapyridine</z:chebi> moiety, the possibility of <z:chebi fb="1" ids="30762">salicylate</z:chebi> sensitivity should be considered in colitic patients who fail to respond appropriately to sulphasalazine or who experience <z:hpo ids='HP_0002027'>abdominal pain</z:hpo> or diarrhoea while taking the drug </plain></SENT>
</text></document>